AGEN Agenus Inc

Price (delayed)

$2.06

Market cap

$558.24M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.1

Enterprise value

$374.85M

Agenus is a clinical-stage immuno-oncology company focused on the discovery and development of therapies that engage the body's immune system to fight cancer. The Company's vision is to expand the ...

Highlights
AGEN's net income has soared by 90% YoY and by 22% QoQ
The EPS has surged by 90% year-on-year and by 9% since the previous quarter
AGEN's equity has soared by 108% YoY but it has shrunk by 54% QoQ
The quick ratio has soared by 84% YoY but it has decreased by 18% from the previous quarter
Agenus's debt has increased by 12% YoY and by 10% QoQ

Key stats

What are the main financial stats of AGEN
Market
Shares outstanding
270.99M
Market cap
$558.24M
Enterprise value
$374.85M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
33.7
Price to sales (P/S)
1.72
EV/EBIT
8.07
EV/EBITDA
7.05
EV/Sales
1.21
Earnings
Revenue
$309.89M
EBIT
$46.45M
EBITDA
$53.17M
Free cash flow
-$32.01M
Per share
EPS
-$0.1
Free cash flow per share
-$0.12
Book value per share
$0.06
Revenue per share
$1.2
TBVPS
$1.58
Balance sheet
Total assets
$441.31M
Total liabilities
$413.66M
Debt
$64.31M
Equity
$15.72M
Working capital
$127.42M
Liquidity
Debt to equity
4.09
Current ratio
1.78
Quick ratio
1.62
Net debt/EBITDA
-3.45
Margins
EBITDA margin
17.2%
Gross margin
99.1%
Net margin
-6%
Operating margin
14.1%
Efficiency
Return on assets
-4.9%
Return on equity
N/A
Return on invested capital
143.9%
Return on capital employed
16.7%
Return on sales
15%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AGEN stock price

How has the Agenus stock price performed over time
Intraday
11.96%
1 week
14.44%
1 month
27.95%
1 year
-62.13%
YTD
-36.02%
QTD
-16.26%

Financial performance

How have Agenus's revenue and profit performed over time
Revenue
$309.89M
Gross profit
$306.98M
Operating income
$43.65M
Net income
-$18.57M
Gross margin
99.1%
Net margin
-6%
AGEN's operating income has surged by 134% year-on-year and by 17% since the previous quarter
AGEN's operating margin has soared by 109% YoY and by 12% from the previous quarter
Agenus's net margin has surged by 97% YoY and by 26% QoQ
AGEN's net income has soared by 90% YoY and by 22% QoQ

Growth

What is Agenus's growth rate over time

Valuation

What is Agenus stock price valuation
P/E
N/A
P/B
33.7
P/S
1.72
EV/EBIT
8.07
EV/EBITDA
7.05
EV/Sales
1.21
The EPS has surged by 90% year-on-year and by 9% since the previous quarter
AGEN's equity has soared by 108% YoY but it has shrunk by 54% QoQ
The stock's price to sales (P/S) is 79% less than its 5-year quarterly average of 7.4 and 77% less than its last 4 quarters average of 6.6
Agenus's revenue has increased by 4.8% from the previous quarter

Efficiency

How efficient is Agenus business performance
The return on sales has surged by 110% year-on-year and by 6% since the previous quarter
Agenus's return on assets has surged by 95% YoY and by 33% QoQ
Agenus's ROIC has decreased by 42% from the previous quarter

Dividends

What is AGEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AGEN.

Financial health

How did Agenus financials performed over time
AGEN's total assets is 7% higher than its total liabilities
AGEN's total assets has soared by 88% YoY but it is down by 5% QoQ
The quick ratio has soared by 84% YoY but it has decreased by 18% from the previous quarter
The debt to equity has surged by 142% since the previous quarter
AGEN's equity has soared by 108% YoY but it has shrunk by 54% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.